The last 150 years have witnessed dramatic improvements in the field of what we now call Neuropsychology. The description of the clinical and cognitive signs of specific brain diseases, as well as our understanding of normal brain function have been considerably improved, thanks to research ranging from anatomoclinical studies to experimental psychology paradigms applied both to patients with brain lesions and to healthy subjects. In the field of dementia, since Dr. Alois Alzheimer presented his first case of the eponymous disorder (Alzheimer, 1907; Jucker, Beyreuther, Haass, Nitsch, & Christen, 2006) roughly a century ago, studies of Alzheimer's disease (AD) have allowed us to characterize the cognitive deficits associated with this neurodegenerative disease far more accurately, thereby improving its diagnosis. They have also informed the modelling of memory (Eustache & Desgranges, 2008) and other cognitive functions, such as language, executive functions, control of behaviour and social cognition (Hodges, 2006) . Research in this area has had a chequered history, with a sixty-year period of relative indifference giving way to a sudden wave of enthusiasm in the early' eighties, bringing together scientists from many disciplines and generating a huge amount of knowledge with a considerable societal impact.
Cognitive neuropsychology has been the driving force behind this reawakening of interest, allowing for a better understanding of the preserved and impaired cognitive processes/systems in the very early stages of different neurodegenerative diseases, through highly informative and comparative approaches. We now know, for instance, that AD is characterized by early and marked deficits in episodic memory, whereas other memory systems (such as procedural memory) remain relatively preserved until a far later stage in the disease (Heindel, Salmon, Shults, Walicke, & Butters, 1989) . Regarding episodic memory, detailed neuropsychological assessments have revealed that deficits not only concern the retrieval of information, but also its encoding (Gainotti & Marra, 1994) . By contrast, memory decline related to normal ageing would appear to stem mainly from retrieval difficulties. These contrasting profiles of memory deficits are particularly important, as they may make it easier to distinguish between normal and pathological ageing. A better understanding of the very early cerebral and cognitive impairments and their mechanisms would contribute to earlier diagnosis of AD and lead to fresh developments in therapeutic intervention strategies. As such, it would constitute a decisive breakthrough from a social, financial and scientific standpoint.
Over the last thirty years, the field of neuropsychology has witnessed considerable developments in cognitive assessments, with the introduction of computerized techniques and virtual reality, together with the emergence of anatomical and functional neuroimaging methods. This decisive shift in methodologies has been parallelled by an impressive growth in our knowledge about cerebral impairments related to brain diseases, including AD. As the disease progresses, the brain changes: it becomes atrophied, its metabolism declines, its resting-state and taskinduced activity drops, amyloid deposits accumulate, brain alpha rhythm amplitude decreases, cholinergic neurotransmission is impaired, etc.
Interestingly, AD-associated changes are not solely characterized by declines, as there are also signs that the brain puts up varied forms of resistance to this attack. There is evidence of increased brain activity in some areas, upregulation of certain neurotransmission systems and additional recruitment of relatively preserved brain regions that may reflect compensatory attempts. Over and above the fact that this brings a positive message amidst all the doom and gloom of the pathological events, these enhancements are particularly interesting, as they represent the brain's natural and ecological defence mechanisms in response to injury which could inspire future pharmacological or nonpharmacological interventions. Moreover, they provide useful information about the physiological mechanisms of brain function and plasticity. Thus, despite the shift in methodologies, neuropsychology continues to pursue the same target as ever, studying brain pathology in order to gain a better understanding not only of the diseased brain but also of normal brain function.
This special issue focuses on early AD, with the specific objective of highlighting the way in which different yet complementary neuroimaging approaches each offer invaluable insight into AD-related brain changes. Although it does not claim to be exhaustive, it does seek to provide a comprehensive overview of the disease, presenting a wide range of points of view via different neuroimaging techniques, from the earliest and most widely used methods employed to study 
